- Home
- FVRR vs COLL Comparison
FVRR vs COLL Comparison
Compare FVRR & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FVRR
- COLL
- Stock Information
- Founded
- FVRR 2010
- COLL 2002
- Country
- FVRR Israel
- COLL United States
- Employees
- FVRR N/A
- COLL N/A
- Industry
- FVRR Business Services
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- FVRR Consumer Discretionary
- COLL Health Care
- Exchange
- FVRR Nasdaq
- COLL Nasdaq
- Market Cap
- FVRR 860.6M
- COLL 1.2B
- IPO Year
- FVRR 2019
- COLL 2015
- Fundamental
- Price
- FVRR $22.64
- COLL $38.93
- Analyst Decision
- FVRR Buy
- COLL Strong Buy
- Analyst Count
- FVRR 10
- COLL 6
- Target Price
- FVRR $31.30
- COLL $42.00
- AVG Volume (30 Days)
- FVRR 468.0K
- COLL 445.3K
- Earning Date
- FVRR 10-30-2024
- COLL 11-05-2024
- Dividend Yield
- FVRR N/A
- COLL N/A
- EPS Growth
- FVRR N/A
- COLL N/A
- EPS
- FVRR 0.29
- COLL 2.43
- Revenue
- FVRR $372,221,000.00
- COLL $576,653,000.00
- Revenue This Year
- FVRR $8.71
- COLL $11.49
- Revenue Next Year
- FVRR $10.09
- COLL $13.94
- P/E Ratio
- FVRR $80.00
- COLL $16.03
- Revenue Growth
- FVRR 8.52
- COLL 7.39
- 52 Week Low
- FVRR $18.83
- COLL $20.95
- 52 Week High
- FVRR $31.61
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- FVRR 38.41
- COLL 53.40
- Support Level
- FVRR $22.83
- COLL $35.76
- Resistance Level
- FVRR $23.82
- COLL $42.29
- Average True Range (ATR)
- FVRR 0.88
- COLL 1.58
- MACD
- FVRR -0.17
- COLL -0.09
- Stochastic Oscillator
- FVRR 0.24
- COLL 48.57
About FVRR Fiverr International Ltd. no par value
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Wiring and Translation, and Video and Animation among others.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.